ストックスクリーナーアプリを入手
37.58
0.50%
-0.245
前日終値:
$37.82
開ける：
$37.98
24時間の取引高:
90,101
Relative Volume:
0.32
時価総額：
$1.31B
収益：
$1.02B
当期純損益:
$35.54M
株価収益率:
43.97
EPS:
0.8546
ネットキャッシュフロー:
$40.81M
1週間 パフォーマンス:
-3.21%
1か月 パフォーマンス:
-10.45%
6か月 パフォーマンス:
+11.63%
1年 パフォーマンス:
+54.92%
1日の値動き範囲:
$37.03
$38.20
1週間の範囲:
$37.03
$39.59
52週間の値動き範囲:
$22.25
$42.69
Pennant Group Inc Stock (PNTG) Company Profile
Compare PNTG vs HCA, THC, FMS, EHC, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PNTG
Pennant Group Inc
|
37.62 | 1.36B | 1.02B | 35.54M | 40.81M | 0.8546 |
HCA
Hca Healthcare Inc
|
418.06 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
266.54 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.04 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.17 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
181.19 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
Pennant Group Inc Stock (PNTG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-08 | 開始されました | William Blair | Outperform |
| 2025-12-02 | アップグレード | Truist | Hold → Buy |
| 2025-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | 開始されました | Jefferies | Buy |
| 2024-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2024-01-05 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-02-27 | アップグレード | Stifel | Hold → Buy |
| 2022-08-25 | 開始されました | Oppenheimer | Outperform |
| 2022-06-21 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-03-01 | ダウングレード | Stifel | Buy → Hold |
| 2021-09-21 | 開始されました | Stifel | Buy |
| 2021-06-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-07-21 | 開始されました | Stephens | Overweight |
| 2020-01-15 | 開始されました | SunTrust | Hold |
| 2019-10-22 | 開始されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Pennant Group Inc (PNTG) 最新ニュース
RBC Raises Price Target on Pennant Group to $44 From $42, Keeps Outperform Rating - marketscreener.com
Pennant Group (PNTG) Climbs 1.76% to $39.32, Holding Ground Above Key SupportDynamic Hedging - vinanet.vn
PNTG Q2 2026 Earnings: EPS Beats Estimates by 6.95% as Stock AdvancesAnnual Financial Report - vinanet.vn
Pennant group CEO Brent Guerisoli sells $165,066 in shares By Investing.com - Investing.com South Africa
Pennant group chief clinical officer sells $53,699 in stock By Investing.com - Investing.com Australia
Pennant group CEO Brent Guerisoli sells $165,066 in shares - Investing.com
Pennant group chief clinical officer sells $53,699 in stock - Investing.com
Pennant group EVP Kirk Cheney sells $53,661 in company stock - Investing.com
PNTG Q2 2026 Earnings: EPS Beat of 6.95% Lifts SharesQuarterly Earnings - vinanet.vn
Will Pennant’s Higher 2026 Guidance and Tucson Acquisition Change Pennant Group's (PNTG) Narrative - simplywall.st
PNTG Q2 2026 Earnings: EPS of $0.36 Beats Estimates by 6.95%, Shares Edge HigherEstimate Accuracy - vinanet.vn
Pennant Group (PNTG) Edges Higher as Shares Hold Above Key Support at $38.64MAMA Signal - vinanet.vn
Pennant Group (PNTG) Climbs 0.68% to $38.64, Holding Above Key SupportWave Truncation - vinanet.vn
How (PNTG) Movements Inform Risk Allocation Models - Stock Traders Daily
Wasatch Advisors LP Raises Position in The Pennant Group, Inc. $PNTG - MarketBeat
Renaissance Technologies LLC Decreases Stock Position in The Pennant Group, Inc. $PNTG - MarketBeat
Wells Fargo & Company Raises The Pennant Group (NASDAQ:PNTG) Price Target to $46.00 - MarketBeat
Wells Fargo raises Pennant Group stock price target on earnings outlook - Investing.com Nigeria
The Pennant Group, Inc. (PNTG) Stock Analysis: A 16.46% Upside In The Healthcare Sector - DirectorsTalk Interviews
Pennant Group Chief Clinical Officer Jason Paul Steik sells 1,394 shares for $53,700.67 - Bitget
Pennant Group CEO Brent Guerisoli Sells 4,285 Shares Under Rule 10b5-1 Plan - Kalkine Media
Pennant Group EVP Kirk Sterling Cheney Sells 1,393 Shares Under 10b5-1 Trading Plan - Kalkine Media
Pennant Group (PNTG) EVP & GC sells 1,393 shares via Rule 10b5-1 plan - Stock Titan
Pennant Group (PNTG) CEO executes 4,285-share planned stock sale at $38.52 - Stock Titan
Pennant Group (PNTG) Chief Clinical Officer sells 1,394 shares in Rule 10b5-1 trade - Stock Titan
Pennant Group (PNTG) Edges Higher as Healthcare Services Sector Gains MomentumHidden Order - vinanet.vn
Pennant Group Inc (PNTG) Stock News Today - TradingKey
The Pennant Group Leverages Technology in Hospice Growth - RamaOnHealthcare
What Pennant Group (PNTG)'s Q2 Beat, Guidance Hike and New Acquisition Means For Shareholders - ca.finance.yahoo.com
Pennant Group sees ‘steady stream’ of senior living deals in second quarter - McKnight's Senior Living
The Pennant Group Q2 Earnings Call Highlights - MarketBeat
Truist Financial Maintains Pennant Group(PNTG.US) With Buy Rating, Announces Target Price $48 - Moomoo
Proposed pay increase ‘a positive signal,’ Pennant CEO says as company reports second-quarter results - McKnights Home Care
Pennant Group Inc (PNTG) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo! Finance Canada
The Pennant Group, Inc. $PNTG Shares Bought by Sei Investments Co. - MarketBeat
Pennant Group, Inc. SEC Filing (Aug 6, 2026) - Stock Titan
Pennant Group (PNTG) insider Brent Guerisoli plans 4,285-share stock sale - Stock Titan
Pennant Group (PNTG) Is Down 5.5% After Raising 2026 Outlook and Expanding Senior Living Footprint - simplywall.st
Earnings call transcript: Pennant Group beats Q2 2026 estimates, raises outlook - Investing.com
The Pennant Group (NASDAQ:PNTG) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
The Pennant Group, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
The Pennant Group (NASDAQ:PNTG) Issues FY 2026 Earnings Guidance - MarketBeat
The Pennant Group (PNTG) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Pennant Group Q2 revenue beats estimates on home health and hospice growth - TradingView
The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full-Year Outlook Slightly Exceeds Expectations - Barchart.com
Pennant Group, Inc. 2026: Revenue $297.98M, EPS $0.25— 10-Q Summary - TradingView
Pennant Group (NASDAQ: PNTG) details Q2 2026 home health and hospice mix - Stock Titan
Earnings Flash (PNTG) The Pennant Group, Inc. Reports Q2 Revenue $298.0M, vs. FactSet Est of $288.7M - marketscreener.com
Earnings Flash (PNTG) The Pennant Group, Inc. Posts Q2 Adjusted EPS $0.36 per Share, vs. FactSet Est of $0.33 - marketscreener.com
Pennant Group (NASDAQ: PNTG) lifts 2026 revenue and EBITDA outlook - Stock Titan
Pennant Group Inc (PNTG) 財務データ
収益
当期純利益
現金流量
EPS
Pennant Group Inc (PNTG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Guerisoli Brent | Chief Executive Officer |
Aug 06 '26 |
Sale |
38.52 |
4,285 |
165,067 |
99,544 |
| Steik Jason Paul | Chief Clinical Officer |
Aug 06 '26 |
Sale |
38.52 |
1,394 |
53,700 |
15,106 |
1.18%
1.93%
大文字化:
|
ボリューム (24 時間):